Synthetic enzymes for controlled drug delivery in cells
The Nanoscopy for Nanomedicine group has studied Single-Chain Polymeric Nanoparticles (SCPNs) mimicking enzymes as possible drug activators in biological environments, like the living cell.
The bio-inspired nanoparticles could be used to spatially control drug delivery in the treatment of diseases such as cancer.
Through their study, published in JACS, the researchers have optimized the delivery strategies of dynamic SCPNs so that they retain their catalytic activity at the cellular environment. This paves the way towards the rational design of nanosystems that can perform effective catalysis in vivo.